INTRODUCTION {#s1}
============

Tuberculosis (TB), caused by *Mycobacterium tuberculosis* (MTB), continues to be a serious infectious disease worldwide \[[@R1], [@R2]\]. It is estimated that most active TB (ATB) cases originate from an initial latent TB infection (LTBI), a state without any clinical symptoms, radiological abnormality, and microbiological evidence. In contrast to adults, young children infected with MTB are more likely to progress to ATB within the first year of primary infection; however, the molecular mechanisms behind this have long been a mystery \[[@R3]\].

MTB infection alters the expression of TB-associated proteins, which are released into the bloodstream through different pathways \[[@R4]\]. Thus, analysis of TB-associated proteins in patients with different MTB infection status might reflect the mechanism of MTB infection and progression. Plasma proteins, such as cytokines, extracellular secretory proteins, and other soluble factors involved in the immune system, are reported to be associated with the pathogenesis of infectious disease \[[@R5]\]. For instance, Shuxian Li *et al.* revealed that the proteins secreted by A549 cells were associated with the infection of *Mycoplasma pneumoniae* \[[@R6]\]. Dandan Xu and her colleagues found that the level of serum proteins (S100A9, SOD3, and MMP9) in ATB reflected the immune response to the MTB infection \[[@R5]\]. Together, the above information implies an important role for proteins in host-pathogen interactions.

Recently, advances in comprehensive analytical techniques, such as proteomics, make the analysis of all plasma proteins possible \[[@R7]\]. Proteomic analysis using the label-free quantitative protocol is a novel approach for high throughput analysis, which provides for a rapid comparison of proteins. Given that a specific mixture of plasma proteins has distinctive characteristics, this technique has been used to investigate the proteomic patterns in many diseases, including infectious diseases \[[@R8]--[@R11]\], vascular diseases \[[@R12]--[@R14]\] and cancer \[[@R15]\]. Thus, analysis of the expression of TB-associated proteins in plasma could provide a better understanding of conversion from LTBI to ATB in children.

Therefore, this study aimed to characterize the plasma proteins in children of different MTB infection status by label-free quantitative proteomics. We observed that 49 proteins were differentially-expressed in the LTBI and ATB groups, and a subset was validated using quantitative real-time PCR (qPCR) and western blotting. Our results will provide insight into the mechanism of MTB infection and progression, as well as potential biomarker selection for the diagnosis of ATB in children.

RESULTS {#s2}
=======

Clinical characteristics {#s2_1}
------------------------

The demographic characteristics of participants showed no obviously differences between groups (Table [1](#T1){ref-type="table"}; age, *P* = 0.625; gender, *P* = 0.318). Among the 19 children in the ATB group, 12 had pulmonary TB, three had tubercular meningitis, one had bone tuberculosis and three had systemic tuberculosis. Among the 17 children in the IDC group, 10 had pneumonia (including both bacterial and viral infections), and seven children had upper respiratory tract infections. Furthermore, the children in inflammatory disease control (IDC) and healthy control (HC) groups had negative interferon gamma release assay (IGRAs) and tuberculin skin test (TST) results, without a history of ATB. All the subjects were vaccinated with BCG.

###### Demographic characteristic of the participants

  Characteristics        ATB         LTBI        IDC         HC
  ---------------------- ----------- ----------- ----------- -----------
  Sample size            19          16          17          20
  Age (years)^a^         6.8 ± 5.1   7.2 ± 3.2   6.9 ± 4.7   7.4 ± 3.5
  Age range (years)      0.2-16      3-11        0.8-15.3    4-14
  Gender (Male/Female)   10/19       8/16        9/17        9/20
  BCG vaccine            19/19       16/16       17/17       20/20

^a^Data are presented as the mean ± SD.

Label-free quantitative proteomics analysis of the differences between ATB and LTBI {#s2_2}
-----------------------------------------------------------------------------------

As respiratory infections are often present in children who have ATB or LTBI, both IDC and HC groups were included in this proteomics analysis. Based on the high throughput proteomics data, a total of 2170 proteins were identified. The plasma, pooled for each group was divided into 3 samples and each liquid chromatography-mass/mass spectrometry (LC-MS/MS) analysis was repeated 3 times.

To detect the proteins that are indicative of MTB infection, we first selected specific proteins whose expression was markedly different between the ATB and control (IDC and HC) groups, and between the LTBI groups and control (IDC and HC) groups. As shown in Figure [1](#F1){ref-type="fig"}, a total of 318 proteins differed in the ATB group, and 521 proteins in the LTBI group (\> 1.5 fold or \< 0.6 fold) when compared with the HC and IDC groups. Of these proteins associated with MTB infection, 49 proteins were differentially expressed between ATB and LTBI. Specifically, 41 proteins were up-regulated (\> 1.5 fold) and 8 proteins were down-regulated (\< 0.6 fold) in the ATB group compared with the LTBI group (Table [2](#T2){ref-type="table"}).

![Different proteins selected through LC-MS/MS analysis\
**(A)** 318 proteins were significantly different in ATB subjects compared with the HC and IDC groups. **(B)** 521 proteins were significantly different in LTBI subjects compared with the HC and IDC groups. **(C)** Among these protein, 49 proteins were markedly different between ATB and LTBI. **(D)** 41 proteins were up-regulated (\>1.5 fold) and 8 proteins were down-regulated (\< 0.6-fold) in the ATB group compared with the LTBI group.](oncotarget-08-103290-g001){#F1}

###### Differentially expressed proteins identified following LC-MS/MS of ATB and LTBI plasma fractions

  Gi number       Protein name                                                                Gene       Uniprot Identifier   mass     pI      ATB:LTBI
  --------------- --------------------------------------------------------------------------- ---------- -------------------- -------- ------- ----------
  gi\|282165800   tight junction protein ZO-2 isoform 5                                       *TJP2*     B7Z2R3               115.10   6.30    ↓
  gi\|6912752     zinc finger protein 281                                                     ZNF281     Q9Y2X9               96.90    9.50    ↓
  gi\|122114658   hypothetical protein LOC23053                                               ZSWIM8     A7E2V4               197.70   6.40    ↓
  gi\|310110387   PREDICTED: hypothetical protein LOC100508795                                \-         \-                   13.60    10.80   ↓
  gi\|296317364   testis-specific serine/threonine-protein kinase 4 isoform 1                 TSSK4      Q6SA08               38.40    9.60    ↓
  gi\|113722125   type II inositol-1,4,5-trisphosphate 5-phosphatase precursor                INPP5B     P32019               103.90   5.10    ↓
  gi\|40556393    protein Jade-1 long isoform                                                 JADE1      Q6IE81               95.50    9.20    ↓
  gi\|20149540    protein-lysine 6-oxidase isoform 1 preproprotein                            LOX        P28300               46.90    9.10    ↓
  gi\|24308211    integrator complex subunit 2                                                INTS2      Q9H0H0               134.30   5.70    ↑
  gi\|105990532   apolipoprotein B-100 precursor                                              APOB       P04114               515.20   6.60    ↑
  gi\|140161498   microtubule-associated tumor suppressor candidate 2 isoform a               MTUS2      Q5JR59               151.10   6.30    ↑
  gi\|33356174    pinin                                                                       PNN        Q9H307               81.60    6.80    ↑
  gi\|169169660   PREDICTED: hypothetical protein LOC100131673                                \-         \-                   50.80    9.40    ↑
  gi\|110611228   utrophin                                                                    UTRN       P46939               394.20   5.10    ↑
  gi\|28872812    MORC family CW-type zinc finger protein 3                                   MORC3      Q14149               107.00   5.30    ↑
  gi\|32307152    oxytocin receptor                                                           OXTR       P30559               42.70    10.90   ↑
  gi\|38016914    SAM domain and HD domain-containing protein 1                               SAMHD1     Q9Y3Z3               72.20    6.80    ↑
  gi\|21361912    dnaJ homolog subfamily C member 1 precursor                                 DNAJC1     Q96KC8               63.80    9.40    ↑
  gi\|157266264   pleckstrin homology-like domain family B member 3                           PHLDB3     Q6NSJ2               71.90    6.10    ↑
  gi\|4504445     heterogeneous nuclear ribonucleoprotein A1 isoform a                        HNRNPA1    P09651               34.20    9.70    ↑
  gi\|148806908   fibronectin type III domain-containing protein 1                            FNDC1      Q4ZHG4               205.40   9.80    ↑
  gi\|303304991   centrosomal protein of 152 kDa isoform 1                                    CEP152     O94986               195.50   5.30    ↑
  gi\|222136639   C-1-tetrahydrofolate synthase, cytoplasmic                                  MTHFD1     P11586               101.50   7.00    ↑
  gi\|59710085    hypothetical protein LOC146562                                              C16orf71   Q8IYS4               55.60    4.70    ↑
  gi\|291045249   collagen alpha-1(XIII) chain isoform 19                                     COL13A1    Q5TAT6               59.40    9.90    ↑
  gi\|54112117    splicing factor 3B subunit 1 isoform 1                                      SF3B1      O75533               145.70   6.70    ↑
  gi\|31377667    lon protease homolog 2, peroxisomal                                         LONP2      Q86WA8               94.60    7.00    ↑
  gi\|7949031     cytochrome P450 2B6                                                         CYP2B6     P20813               56.20    9.10    ↑
  gi\|51702222    protein SPT2 homolog                                                        SPTY2D1    Q68D10               75.60    10.30   ↑
  gi\|150421681   probable phospholipid-transporting ATPase IH isoform b                      ATP11A     P98196               135.80   6.30    ↑
  gi\|55741447    pleckstrin homology domain-containing family H member 1                     PLEKHH1    Q9ULM0               151.10   9.00    ↑
  gi\|33620745    pre-mRNA cleavage complex 2 protein Pcf11                                   PCF11      O94913               172.90   9.30    ↑
  gi\|38027923    COP9 signalosome complex subunit 5                                          COPS5      Q92905               37.60    6.10    ↑
  gi\|45827701    protein dopey-2                                                             DOPEY2     Q9Y3R5               258.10   5.90    ↑
  gi\|118421085   treslin                                                                     TICRR      Q7Z2Z1               210.70   9.80    ↑
  gi\|113416493   PREDICTED: putative TAF11-like protein ENSP00000332601-like                 \-         \-                   21.60    7.70    ↑
  gi\|159032029   sentrin-specific protease 5                                                 SENP5      Q96HI0               86.60    10.10   ↑
  gi\|28827774    dual specificity tyrosine-phosphorylation-regulated kinase 4                DYRK4      Q9NR20               59.60    9.70    ↑
  gi\|40804748    LIM and senescent cell antigen-like-containing domain protein 2 isoform 2   LIMS2      Q7Z4I7               41.50    10.10   ↑
  gi\|5454058     CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 4    ST3GAL4    Q11206               37.40    10.00   ↑
  gi\|19923437    GTP:AMP phosphotransferase, mitochondrial                                   AK3        Q9UIJ7               25.50    9.50    ↑
  gi\|50659100    inactive serine protease PAMR1 isoform b                                    PAMR1      Q6UXH9               80.10    8.80    ↑
  gi\|4507945     DNA repair protein XRCC4 isoform 1                                          XRCC4      Q13426               38.00    4.80    ↑
  gi\|164519084   rab GTPase-activating protein 1                                             RABGAP1    Q9Y3P9               121.70   5.00    ↑
  gi\|98986457    host cell factor 1                                                          HCFC1      P51610               208.60   7.90    ↑
  gi\|310123245   PREDICTED: Golgin subfamily A member 8-like protein 2-like, partial         \-         \-                   62.60    6.20    ↑
  gi\|300863076   semaphorin-4A isoform 2                                                     SEMA4A     Q9H3S1               69.10    6.30    ↑
  gi\|310113571   PREDICTED: hypothetical protein LOC100508805                                \-         \-                   68.60    6.60    ↑
  gi\|46409310    zinc finger protein 467                                                     ZNF467     Q7Z7K2               65.10    11.00   ↑

To reveal the relationship between the 49 different proteins, a hierarchical clustering based on Pearson correlation of variances was applied using R studio. Figure [2A](#F2){ref-type="fig"} depicts hierarchical clustering of the 49 identified proteins, where an increasingred color indicates increasing protein expression levels. Thus, the most prominent area of up-regulation in ATB subjects was seen in the region where these protein peaks are shown in red. Furthermore, important features were selected by a volcano plot (Figure [2B](#F2){ref-type="fig"}).

![Heat map and volcano plot of the 49 identified proteins\
**(A)** The most striking area of up-regulation in ATB patients is seen in the region where a series of protein peaks are shown in red. **(B)** Important features selected by volcano plot.](oncotarget-08-103290-g002){#F2}

Gene ontology analysis of the identified proteins {#s2_3}
-------------------------------------------------

To further understand the functions of these identified proteins, we classified the 49 differential proteins between LTBI and ATB by their Gene Ontology (GO) categories, including cellular component (CC), molecular function (MF), and biological process (BP) using the Web Gene Ontology Annotation Plotting (WEGO, Figure [3](#F3){ref-type="fig"}, [Supplementary Table 1](#SD2){ref-type="supplementary-material"} and [2](#SD1){ref-type="supplementary-material"}). According to the analysis of CC, the majority of the proteins had a cell and organelle distribution. According to the analysis of BP, the primary functions were cellular processes, metabolic processes and biological regulation; while others were related to cellular component organization, pigmentation, multicellular organismal processes and so on. According to the analysis of MF, these proteins could be classified into eight categories as follows: molecular transducer activity, translation regulator activity, enzyme regulator activity, transcription regulator activity, structural molecule activity, catalytic activity, binding, transporter activity. Among them, a large proportion had binding as a molecular function. To identify the most important proteins involved in the conversion from LTBI to ATB, proteins that were obviously up or down-regulated should be categorized into many different functional groups.

![Web Gene Ontology Annotation Plot (WEGO) classification of differentially expressed proteins by label-free quantitative proteomics experiments between ATB and LTBI\
The differentially expressed proteins are grouped into three hierarchically structured terms: biological process, cellular component, and molecular function.](oncotarget-08-103290-g003){#F3}

KEGG enrichment analysis of the identified proteins {#s2_4}
---------------------------------------------------

KEGG enrichment analysis was then implemented to test enrichment of the proteomics pathways between the LTBI and ATB groups. The results indicated that mRNA surveillance pathway (*P* = 0.018), Non-homologous end-joining (*P* = 0.034) and Spliceosome (*P* = 0.040), One carbon pool by folate (*P* = 0.049) were significantly associated with the conversion from LTBI to ATB (Figure [4](#F4){ref-type="fig"} and [Supplementary Table 3](#SD1){ref-type="supplementary-material"}).

![KEGG enrichment analysis of the differentially expressed proteins](oncotarget-08-103290-g004){#F4}

Validation of proteomic results {#s2_5}
-------------------------------

Proteins identified as differentially expressed in ATB and LTBI patients were validated using qPCR and western blotting. Among the 49 different proteins, four (XRCC4, PCF11, SEMA4A and ATP11A) were selected for further verification. The selection of the proteins for the verification stage was based on the following criteria: (1) high fold change; (2) being representative of the 49 different proteins; (3) *P* value of \<0.05 in KEGG analysis (XRCC4 and PCF11) or having biological functions associated with immunity and other infectious diseases (SEMA4A and ATP11A). Although these four proteins were mainly distributed in cellular parts, their functions were different. Most proteins different between the ATB and LTBI groups were related to binding, cellular and metabolic process and these four selected proteins were associated with these processes. Firstly, the four selected proteins all were also participate in the binding processes, including nucleic acid binding and protein binding. Additionally, XCRR4 and PCF11 had an effect on metabolic process while SEMA4A and ATP11A were related to the cellular process. Thus, these four proteins, being representative of the 49 different proteins, reflected the different status of MTB infection.

At the mRNA level, the expression of XRCC4, PCF11and SEMA4A presented an increased trend in ATB group compare with that in LTBI and this agreed with the proteomic results. The ratio of ATP11A was apparently inconsistent with the proteomic data (Figure [5A](#F5){ref-type="fig"}). The mRNA result implies that regulation is occurring at the point of protein translation, not gene transcription. At the protein level, our results demonstrated that the plasma levels of XRCC4, PCF11, SEMA4A and ATP11A in the ATB group were significantly higher than the LTBI group (all *P* \< 0.05; Figure [5B](#F5){ref-type="fig"}). Representative western blots are shown in Figure [5C](#F5){ref-type="fig"}. These ratios were consistent with the trends of proteomics results. Total protein staining by Coomassie Blue employed as the loading control (Figure [5D](#F5){ref-type="fig"}).

![Verification of up- or down-regulated proteins between ATB and LTBI\
**(A)** RT-PCR analysis data of four selected proteins in the PBMCs of ATB patients compared with that of LTBI patients (n~ATB~ = 28, n~LTBI~ = 18); data are presented as means ± SD. **(B)** The average signals of ATB and LTBI patients group (*P* \< 0.05, n = 5 per group); data are presented as means ± SD. **(C)** Western blot analysis of the four selected proteins from ATB and LTBI subjects (n=5 per group). **(D)** Total protein staining by Coomassie Blue employed as the loading control.](oncotarget-08-103290-g005){#F5}

DISCUSSION {#s3}
==========

It is generally known that the immune response induced by MTB infection influences the pathogenic mechanisms and protein expression \[[@R16]\]. Specifically, TB-associated proteins appear in the circulation by a variety of mechanisms, including direct secretion of proteins, stimulated production of reactive proteins, or production of proteins during the infection of the MTB \[[@R17], [@R18]\]. Accurate detection TB-associated proteins lead to a better understanding of the mechanism of MTB infection and progression.

Plasma proteins including cytokines, extracellular secretory proteins, growth factors, and other soluble factors, contribute to many physiological processes. Recently, researchers have demonstrated that proteins are also significantly associated with different diseases. For instance, the secretion of adiponectin is associated with the development of many cardiovascular related diseases \[[@R19]\]. Similarly, plasma proteins also have profound effects on a variety of infectious diseases. For example, during herpes simplex virus 1 (HSV-1) infection, increased IFN-induced protein expression is reported to play an essential role in extracellular antiviral functions \[[@R20]\]. Similarly, the secretion of proteins may increase the number of CD4^+^ T cells \[[@R21]\]. Taken together, the above data show the importance of plasma proteins during pathogen infection.

This study demonstrated a difference in plasma protein pattern in MTB infection in children. As respiratory infections are often present in children who have ATB or LTBI, we included both IDC and HC groups in this proteomic analysis. To detect differences that are indicative of MTB infection, we first selected specific proteins whose expression was markedly different in ATB or LTBI groups compared with controls (the IDC and HC groups). Among these proteins, 49 were differentially expressed between LTBI and ATB. These proteins were further performed by volcano plot. The traditional volcano plot is a combination of fold change and t-tests. Note, for unpaired samples, the x-axis is log (FC). Y-axis is -log10 (*P*-value) for both cases, and can be based on raw or FDR adjusted *P* values. However, our data alignment strategy is: disease control and normal control, respectively, compared with ATB and LTBI, followed look at the difference between the significant difference between the part of ATB and LTBI. In our data, the three biological repetitions and three technical repetitions combined after the comparison, so cannot achieve the traditional meaning of the volcano show. Figure [2B](#F2){ref-type="fig"} just showed the different proteins between ATB and LTBI.

These plasma proteins were further subjected to a GO enrichment analysis which clustered proteins based on three defined ontology terms: GO-CC, GO-BP and GO-MF \[[@R22]\]. Here, we observed that most of these proteins were present in the isolated cell or organelle fraction. Similarly, released intracellular proteins were detected in MTB-infected plasma, suggesting the importance of these associated proteins at the lesions created by MTB infection. In addition, other identified proteins were associated with protein binding. These results demonstrate that the proteins affecting the MTB infection status were related to DNA and protein binding, cellular and metabolic processes.

Among the 49 differentially expressed proteins, XRCC4, PCF11, SEMA4A and ATP11A were selected for further validation. The above functional analysis demonstrated that most different proteins influencing the MTB infection status were mainly related to binding, cellular and metabolic processes. The four selected proteins were all associated with these processes. It is well known that binding is the first step of the MTB infection and these four selected proteins were all participate in the binding process, including nucleic acid binding and protein binding. Furthermore, MTB infection also changes metabolic processes. XCRR4 and PCF11 influence metabolic processes and were significantly different between the ATB and LTBI groups. According to the GO analysis, SEMA4A and ATP11A, which are related to cellular processes, also had an important role in MTB infection.

The levels of mRNA after MTB infection did not correlate with the proteins level. A similar result demonstrated that when the most induced proteins in human mesenchymal stromal cells (HMSCs) were assayed by qPCR, the results do not match the results detected by MS \[[@R23]\]. This is a limitation of the current study.

The selected proteins have previously been reported to be associated with immunity and other infectious diseases \[[@R24]--[@R35]\]. XRCC4 is an important component of non-homologous end-joining \[[@R24]\]. The expression of this gene is associated with many infectious diseases, including HSV-1 \[[@R25], [@R26]\]. In addition, PCF11serves as a target for regulated transcription and pre-mRNA processing. Recent studies showed that it is also involved in regulated transcription initiation, elongation, termination and alternative processing of pre-mRNA \[[@R27]--[@R29]\]. SEMA4A is expressed by dendritic cells, macrophages, and activated T cells \[[@R30], [@R31]\]. It is involved in co-stimulation in helper T cell proliferation and cytokine production \[[@R32], [@R33]\]. Higher levels of SEMA4A in ATB group implied the higher T cell activation in MTB infection than in LTBI. ATP11A, a member of P4-ATPases, is a lipid flippase \[[@R34]\]. A previous study demonstrated that lipid flippases are essential to mediate the endotoxin-induced endocytosis of Toll-like receptor 4 in human macrophages. Macrophages play a primary role in TB transmission \[[@R35]\]. MTB usually replicates within macrophages and spreads to pulmonary lymph nodes. Furthermore, lipid flippase is also important to dampen the inflammatory response, implying that ATP11A had an important effect in MTB infection. Our results indicate, for the first time, that the expression of these proteins were also correlated with the conversion from LTBI to ATB in children.

Because of the difficulty of enrolling LTBI pediatric subjects, a limitation of this study is the relatively small sample size used for verification. Thus, a larger sample size and further mechanism analysis should be the focus of future investigations.

In conclusion, we identified 49 differentially expressed plasma proteins related to the differential status of MTB infection by the label-free quantitative method. After analyzing the protein functions and regulatory networks, XRCC4, PCF11, SEMA4A and ATP11A were selected and further verified by qPCR and western blot. Our results will provide important data for molecular mechanism studies and biomarker selection during MTB infection.

MATERIALS AND METHODS {#s4}
=====================

Patients and controls {#s4_1}
---------------------

Respiratory infectious diseases overlapping with TB in children are very common. Therefore, to detect the differences that are indicative of MTB infection, IDC and HC were also included in this study.

A total of 72 children (19 ATB, 16 LTBI, 17 IDC and 20 HC) were enrolled at Beijing Children's Hospital between July 2010 to May 2013. The diagnosis of pediatric ATB was according to the guidelines of the Chinese Medical Association: (1) MTB culture result was positive, or (2) at least one symptom, sign, or radiographic evidence was consistent with ATB, or (3) clinical and radiological improvement was seen following anti-TB chemotherapy \[[@R2]\]. To accurately reflect the MTB infection status, all the ATB sera were collected before anti-TB chemotherapy.

LTBI was defined as (1) positive by both IGRAs and TST, (2) exposure history to a known ATB case, (3) no clinical, radiological and microbiological evidence of active TB \[[@R36]\].

IDC group subjects were enrolled according to their respiratory symptoms and negative IGRAs and TST results (\<5mm) to exclude ATB and LTBI. HC group subjects were recruited from children admitted to Beijing Children's Hospital for physical examination from June 2012 to May 2013. The IDC and HC controls with negative IGRAs and TST results, had not been previously infected with TB, HIV or other infectious diseases. Each group was matched by age, sex, and ethnicity.

At the qPCR verification stage, we utilized the peripheral blood mononuclear cell (PBMC) samples from 28 ATB (18 boys and 10 girls; median age 5.0 years, range 0.4--12 years) and 18 age- and gender-matched LTBI subjects(12 boys and 6 girls; median age 5.6 years, range 0.25--15 years). At the western blot verification stage, the plasma of 5 ATB (3 boys and 2 girls; median age 8.3 years, range 3--12 years) and 5 age- and gender-matched LTBI subjects (2 boys and 3 girls; median age 7.6 years, range 3--11 years) were collected. The diagnosis criteria of pediatric ATB and LTBI outlined above. All the subjects had the positive IGRAs and TST results.

The study was approved by the Ethics Committee of Beijing Children's Hospital. All the methods and experimental protocols in this research were performed according to the approved protocols and the Ethics Committees' existing guidelines. The parents of all children provided written, informed consent prior to their enrollment in the study.

Protein extraction and digest {#s4_2}
-----------------------------

Human plasma samples were pooled for each group and divided into 3 aliquots. Albumin, IgG, IgA, antitrypsin, transferrin and haptoglobin were removed by the Agilent Multiple Affinity Removal Column (Multiple Affinity Removal Column, 4.6 mm × 50 mm; Agilent Technologies, Palo Alto, CA, USA). After being resuspended with PBS (50 μL), the samples were centrifuged at 10,000*g* for 30 min in 4°C and resuspended with 100 μL lysis buffer (7 M urea, 2 M thiourea). Total proteins were extracted by ultrasonic sonication and precipitated with trichloroacetic acid (TCA) for 30 min on ice before centrifuging at 40,000*g* for 30 min. Next, the protein concentration was adjusted with 50 mM NH~4~HCO~3~ to a final concentration of 0.5mg/mL and then mixed with DTT (5μl, 1mol/L) and incubated at 37°C for 60 min. After incubation with IAA (20μL, 1mol/L) for 60 min in the dark, the samples were digested with trypsin at 37°C for 12 h \[[@R17]\].

LC-MS/MS analysis {#s4_3}
-----------------

Peptide mixtures were used for protein identification by nano-liquid chromatography coupled with MS. The LC-MS/MS system consisted of an Agilent 1100 quaternary HPLC (EASY-nLC1000) and a micrOTOF-Q II mass spectrometer (Bruker Daltonics, USA) with the application of a distal 180°C source temperature. A RP trapcolumn (Thermo EASY column SC200 150μm×100mm) was used for desalting, and a C18 reverse-phase column (Thermo EASY column SC001 traps 150μm × 20mm) was used for separation. Mobile phase A consisted of HPLC-grade water containing 0.1% formic acid (FA), and phase B consisted of 84% HPLC-grade acetonitrile (ACN) containing 0.1% FA. The analytical separation was run at a flow rate of 400 nl/min using a linear gradient of phase B as follows: 0--45% for 100 min, 45--100% for 8 min and 100% for 12 min. To reduce the technical variation the analyses were repeated three times \[[@R37]\]. Peptide spectral matches (PSMs) were validated using the percolator provided by the Proteome Discoverer software based on q-values at a 1% false discovery rate.

Normalization by a reference sample, also known as probabilistic quotient normalization, is a robust method to account for different dilution effects of biofluids. This method is based on the calculation of a most probable dilution factor (median) by looking at the distribution of the quotients of the amplitudes of a test spectrum by those of a reference spectrum \[[@R38]\].

Bioinformatics analysis {#s4_4}
-----------------------

For protein identification, the Mascot 2.1 program (Matrix Science, Boston, MA, USA) was used for fragmentation spectra research, which was searched against the human database. Two missed cleavages were permitted, and an error of 6 ppm or 20 ppm was allowed for full MS or MS/MS spectra study, respectively. Furthermore, we used the resulting MGF documents and Data Analysis 3.4 from Bruker Daltonics Software to detect the fold-changes of the protein levels of each group. The identified proteins were analyzed by GO categories using the Web Gene Ontology Annotation Plotting (WEGO, <http://wego.genomics.org.cn/cgi-bin/wego/index.pl>). Signaling pathway analysis was performed by Kyoto Encyclopedia of Genes and Genome (KEGG) database (<http://www.genome.jp/kegg/pathway.html>) \[[@R39]\].

Proteins used for validation were selected by molecular function and the biological process or pathway term in PANTHER.

Quantitative real-time PCR {#s4_5}
--------------------------

Total RNA was obtained using miRNeasy Mini Kits (Qiagen, Valencia, CA, USA) according to the manufacturer's instructions. Subsequently, 500 ng of the RNA was reverse transcribed to cDNA using ReverTra Ace qPCR RT Kits(TOYOBO, Osaka, Japan), and quantitative real-time PCR was carried out with a 7900 HT Sequence Detection System (ABI, Foster City, CA, USA) using ABI Power SYBR Green PCR Master Mix. The raw data were normalized using the Quantile algorithm in GeneSpring 11.0 (Agilent Technologies, Santa Clara, CA, USA). The thermal cycling conditions were: 2 min at 95°C for initial denaturation, followed by 40 cycles of 15 sec at 95°C, 60 sec at 60°C for amplification, and 15 sec at 95°C, 15 sec at 60°C and 15 sec at 95°C for melting curve analysis \[[@R6]\]. Target gene primers are listed in [Supplementary Table 4](#SD1){ref-type="supplementary-material"}.

Western blot {#s4_6}
------------

Western bloting was performed as described previously, with minor differences \[[@R6]\]. Briefly, proteins extracted from plasma, were separated using 12% SDS-PAGE gels and transferred to PVDF membranes (Millipore, Billerica, MA, USA). For detection, after incubation with primary antibodies overnight at 4°C, the membranes were washed three times with Tris-buffered saline containing Tween-20 (TBS-T), and incubated with horseradish peroxidase (HRP) - conjugated secondary antibodies (1:5000; Santa Cruz, Dallas, TX, USA) for 2 h at room temperature. Antibody binding was visualized using the Enhanced Chemi Luminescence Kit (ECL-Kit, Santa Cruz) after being washed in PBS-T. The primary antibodies used in this experiment included rabbit polyclonal anti-XRCC4 antibody (Abcam, Cambridge, MA, USA, diluted 1:1000), rabbit polyclonal anti-PCF11 antibody (Abcam, diluted 1:2000), rabbit polyclonal anti-SEMA4A antibody (Abcam, diluted 1:1000), rabbit polyclonal anti-ATP11A antibody (Santa Cruz, diluted 1:1000), and mouse monoclonal anti-β-actin antibody (Upstate, Lake Placid, NY, USA; diluted 1:2000).

Ten μg protein was loaded per lane of a 1-mm-thick mini polyacrylamide SDS-gel. The proteins were stained with Coomassie Blue as an internal control for normalization \[[@R40]\] Proteins were transferred to a NC membrane for 1h using Bio-rad Trans-Blot. After being blocked with 3% BSA for 30min, the target proteins were incubated with primary antibody and associated secondary to each blot with at least four, 3-minute wash steps.

Statistical analysis {#s4_7}
--------------------

Each experiment was repeated independently at least three times. Data are expressed as the mean ± SD and differences between groups were evaluated with the Student t-test or Mann-Whitney U test. Values of *P*\<0.05 were considered statistically significant.

SUPPLEMENTARY MATERIALS TABLES {#s5}
==============================
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